SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4RB'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A 19 VAL A 27 ALA A 40 GLU A 64 ILE A 71 GLY A 99	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) GOL A 503 (-2.8A) None None	0.72A	1iepB-3bqrA: 20.6	1iepB-3bqrA: 26.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	ALA A 40 GLU A 64 LEU A 68 LEU A 130 HIS A 137	4RB A 401 (-3.3A) GOL A 503 (-2.8A) None None None	0.54A	1uwhA-3bqrA: 22.5	1uwhA-3bqrA: 27.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	ALA A 40 LYS A 42 GLU A 64 LEU A 68 LEU A 130 HIS A 137	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None None None	0.60A	1uwhB-3bqrA: 22.4	1uwhB-3bqrA: 27.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 9	LEU A 19 VAL A 27 LEU A 79 LEU A 91 LEU A 95	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) PGO A 501 ( 4.6A) None 4RB A 401 (-4.4A)	0.47A	1xkkA-3bqrA: 20.9	1xkkA-3bqrA: 24.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YI4_A_ADNA306_1 (PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 10	LEU A 19 ALA A 40 ILE A 77 LEU A 93 ILE A 160	4RB A 401 ( 3.9A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.3A) 4RB A 401 ( 4.1A) 4RB A 401 (-3.5A)	0.80A	1yi4A-3bqrA: 26.1	1yi4A-3bqrA: 30.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	LEU A 19 VAL A 27 ALA A 40 VAL A 96 ASP A 139 LYS A 141 ASN A 144 MET A 146	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) None None None 4RB A 401 (-2.8A)	0.84A	2fumA-3bqrA: 25.8	2fumA-3bqrA: 28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	VAL A 27 ALA A 40 VAL A 96 ASP A 139 LYS A 141 ASN A 144 MET A 146 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) None None None 4RB A 401 (-2.8A) GOL A 503 ( 3.1A)	0.77A	2fumA-3bqrA: 25.8	2fumA-3bqrA: 28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A 19 GLY A 20 VAL A 27 ALA A 40 VAL A 96 MET A 146	4RB A 401 ( 3.9A) 4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) 4RB A 401 (-2.8A)	0.82A	2fumC-3bqrA: 24.5	2fumC-3bqrA: 28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A 19 VAL A 27 ALA A 40 VAL A 96 ASN A 144 MET A 146	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) None 4RB A 401 (-2.8A)	0.81A	2fumC-3bqrA: 24.5	2fumC-3bqrA: 28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITY_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	LEU A 19 GLY A 20 VAL A 27 ALA A 40 LYS A 42 GLU A 64 LEU A 91 ASP A 161	4RB A 401 ( 3.9A) 4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None GOL A 503 ( 3.1A)	0.75A	2ityA-3bqrA: 22.4	2ityA-3bqrA: 25.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	GLY A 20 VAL A 27 ALA A 40 LEU A 93 MET A 146 ASP A 161	4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) 4RB A 401 (-2.8A) GOL A 503 ( 3.1A)	0.74A	2wgjA-3bqrA: 20.9	2wgjA-3bqrA: 25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YGQ_A_PCFA1275_0 (WNT INHIBITORY FACTOR 1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	LEU A 210 ILE A 123 LEU A 159 ILE A 206 ILE A 160	None None None None 4RB A 401 (-3.5A)	1.04A	2ygqA-3bqrA: undetectable	2ygqA-3bqrA: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	ALA A 40 GLU A 64 LEU A 68 ILE A 77 HIS A 137 ASP A 161	4RB A 401 (-3.3A) GOL A 503 (-2.8A) None 4RB A 401 ( 4.3A) None GOL A 503 ( 3.1A)	1.17A	3gp0A-3bqrA: 21.0	3gp0A-3bqrA: 27.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	VAL A 27 ALA A 40 GLU A 64 LEU A 68 ILE A 77 HIS A 137	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) GOL A 503 (-2.8A) None 4RB A 401 ( 4.3A) None	0.65A	3gp0A-3bqrA: 21.0	3gp0A-3bqrA: 27.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	ALA A 40 LYS A 42 GLU A 64 LEU A 68 LEU A 95	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None 4RB A 401 (-4.4A)	0.56A	3hecA-3bqrA: 21.0	3hecA-3bqrA: 28.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	ALA A 40 LYS A 42 LEU A 68 ILE A 77 LEU A 95	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None 4RB A 401 ( 4.3A) 4RB A 401 (-4.4A)	0.66A	3hecA-3bqrA: 21.0	3hecA-3bqrA: 28.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	VAL A 27 ALA A 40 LYS A 42 LEU A 68 ILE A 77	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None 4RB A 401 ( 4.3A)	0.60A	3hegA-3bqrA: 20.7	3hegA-3bqrA: 28.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 8	ALA A 40 LYS A 42 GLU A 64 LEU A 91 LEU A 95	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None 4RB A 401 (-4.4A)	0.53A	3lfaA-3bqrA: 21.2	3lfaA-3bqrA: 27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_A_1N1A1000_1 (P38A)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	GLY A 20 VAL A 27 ALA A 40 LYS A 42 LEU A 68 ILE A 77	4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None 4RB A 401 ( 4.3A)	0.61A	3ohtA-3bqrA: 4.0	3ohtA-3bqrA: 25.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_B_1N1B1000_1 (P38A)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	GLY A 20 VAL A 27 ALA A 40 LYS A 42 LEU A 68 ILE A 77	4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None 4RB A 401 ( 4.3A)	0.61A	3ohtB-3bqrA: 18.6	3ohtB-3bqrA: 25.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	VAL A 27 ALA A 40 GLU A 64 LEU A 68 ILE A 77 LEU A 130 HIS A 137	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) GOL A 503 (-2.8A) None 4RB A 401 ( 4.3A) None None	0.58A	3rgfA-3bqrA: 21.8	3rgfA-3bqrA: 26.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	LEU A 19 VAL A 27 ALA A 40 LYS A 42 LEU A 91 LEU A 95 ASP A 103	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None 4RB A 401 (-4.4A) None	0.70A	3ug2A-3bqrA: 21.7	3ug2A-3bqrA: 25.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WAR_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 8	LYS A 42 ILE A 77 MET A 146 ILE A 160 ASP A 161	4RB A 401 ( 2.8A) 4RB A 401 ( 4.3A) 4RB A 401 (-2.8A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.38A	3warA-3bqrA: 24.5	3warA-3bqrA: 27.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WAR_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 8	VAL A 27 LYS A 42 ILE A 77 MET A 146 ILE A 160	4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.3A) 4RB A 401 (-2.8A) 4RB A 401 (-3.5A)	0.38A	3warA-3bqrA: 24.5	3warA-3bqrA: 27.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	LEU A 19 VAL A 27 ALA A 40 LYS A 42 LEU A 68 ILE A 71 HIS A 137	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None None None	0.61A	3wzeA-3bqrA: 20.2	3wzeA-3bqrA: 27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	VAL A 27 ALA A 40 LYS A 42 LEU A 68 ILE A 71 LEU A 130 HIS A 137	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None None None None	0.65A	3wzeA-3bqrA: 20.2	3wzeA-3bqrA: 27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	LEU A 19 ALA A 40 LEU A 93 LEU A 95 ASP A 161	4RB A 401 ( 3.9A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) 4RB A 401 (-4.4A) GOL A 503 ( 3.1A)	0.42A	3zbfA-3bqrA: 23.3	3zbfA-3bqrA: 25.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ASD_A_BAXA1500_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	9 / 12	LEU A 19 VAL A 27 ALA A 40 LYS A 42 GLU A 64 LEU A 68 GLY A 99 LEU A 130 HIS A 137	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None None None None	0.82A	4asdA-3bqrA: 20.0	4asdA-3bqrA: 25.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	VAL A 27 ALA A 40 ILE A 77 ASP A 103 ASP A 139 ASN A 144 ILE A 160 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.3A) None None None 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.61A	4i41A-3bqrA: 26.0	4i41A-3bqrA: 29.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	VAL A 27 ALA A 40 ILE A 77 ASP A 103 ASP A 139 LYS A 141 ASN A 144 ILE A 160	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.3A) None None None None 4RB A 401 (-3.5A)	0.68A	4i41A-3bqrA: 26.0	4i41A-3bqrA: 29.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 11	VAL A 27 ALA A 40 LYS A 42 LEU A 93 ILE A 160 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.1A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.40A	4iaaA-3bqrA: 26.0	4iaaA-3bqrA: 29.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	GLY A 20 VAL A 27 ALA A 40 LEU A 79 LEU A 91 GLY A 99 GLU A 100 ILE A 160	4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) PGO A 501 ( 4.6A) None None 4RB A 401 (-3.8A) 4RB A 401 (-3.5A)	0.46A	4ifgA-3bqrA: 25.0	4ifgA-3bqrA: 23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	LEU A 19 VAL A 27 ALA A 40 LYS A 42 LEU A 93 LEU A 95 ASP A 161	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.1A) 4RB A 401 (-4.4A) GOL A 503 ( 3.1A)	0.50A	4mkcA-3bqrA: 21.7	4mkcA-3bqrA: 23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 10	ALA A 40 LYS A 42 ILE A 77 LEU A 95 VAL A 96	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.3A) 4RB A 401 (-4.4A) 4RB A 401 ( 4.1A)	0.45A	4rz7A-3bqrA: 6.9	4rz7A-3bqrA: 14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	ALA A 40 GLU A 64 ILE A 71 LEU A 130 HIS A 137	4RB A 401 (-3.3A) GOL A 503 (-2.8A) None None None	0.83A	4v01A-3bqrA: 20.2	4v01A-3bqrA: 25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A 19 ALA A 40 LYS A 42 GLU A 64 LEU A 91 LEU A 95	4RB A 401 ( 3.9A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None 4RB A 401 (-4.4A)	0.49A	4wkqA-3bqrA: 22.3	4wkqA-3bqrA: 25.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	ALA A 40 LYS A 42 LEU A 68 ASP A 161 PHE A 162	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None GOL A 503 ( 3.1A) None	0.76A	4xv2B-3bqrA: 22.7	4xv2B-3bqrA: 28.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	VAL A 27 ALA A 40 LYS A 42 LEU A 68 PHE A 162	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None None	0.73A	5cswA-3bqrA: 22.4	5cswA-3bqrA: 28.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	VAL A 27 ALA A 40 LYS A 42 LEU A 68 PHE A 162	4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) None None	0.75A	5cswB-3bqrA: 22.4	5cswB-3bqrA: 28.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	ALA A 40 LYS A 42 GLU A 64 LEU A 68 LEU A 130 HIS A 137	4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None None None	0.70A	5hi2A-3bqrA: 23.2	5hi2A-3bqrA: 28.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	GLY A 20 GLY A 22 LYS A 42 GLU A 100	4RB A 401 (-3.6A) None 4RB A 401 ( 2.8A) 4RB A 401 (-3.8A)	0.52A	5izfA-3bqrA: 20.4	5izfA-3bqrA: 26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	GLY A 20 GLY A 22 VAL A 27 LYS A 42	4RB A 401 (-3.6A) None 4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A)	0.37A	5izjA-3bqrA: 19.3	5izjA-3bqrA: 26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 7	GLY A 20 GLY A 22 VAL A 27 LYS A 42 ASP A 161	4RB A 401 (-3.6A) None 4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) GOL A 503 ( 3.1A)	0.78A	5j5xA-3bqrA: 26.0	5j5xA-3bqrA: 26.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-D EPENDENT PROTEIN KINASE 1)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 11	LEU A 19 GLY A 20 VAL A 27 ALA A 40 LEU A 93 GLU A 100	4RB A 401 ( 3.9A) 4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.1A) 4RB A 401 (-3.8A)	0.47A	5lvnA-3bqrA: 27.8	5lvnA-3bqrA: 27.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 10	GLY A 20 VAL A 27 ALA A 40 ILE A 77 LEU A 95	4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 4.3A) 4RB A 401 (-4.4A)	0.65A	5lw1E-3bqrA: 20.6	5lw1E-3bqrA: 12.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	8 / 12	GLU A 17 GLY A 20 VAL A 27 ALA A 40 LYS A 42 GLU A 64 LEU A 93 GLU A 100	None 4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) 4RB A 401 ( 4.1A) 4RB A 401 (-3.8A)	0.83A	5mafA-3bqrA: 28.5	5mafA-3bqrA: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	9 / 12	GLU A 17 GLY A 20 VAL A 27 ALA A 40 LYS A 42 LEU A 93 GLY A 99 GLU A 100 ILE A 160	None 4RB A 401 (-3.6A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.1A) None 4RB A 401 (-3.8A) 4RB A 401 (-3.5A)	0.80A	5mafA-3bqrA: 28.5	5mafA-3bqrA: 13.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A 19 VAL A 27 ALA A 40 LYS A 42 GLU A 64 LEU A 91	4RB A 401 ( 3.9A) 4RB A 401 ( 4.4A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None	0.66A	5vcyA-3bqrA: 23.9	5vcyA-3bqrA: 26.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_B_IREB401_0 (CYCLIN-G-ASSOCIATED KINASE)	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	7 / 12	LEU A 19 ALA A 40 LYS A 42 GLU A 64 LEU A 91 LEU A 95 ASP A 161	4RB A 401 ( 3.9A) 4RB A 401 (-3.3A) 4RB A 401 ( 2.8A) GOL A 503 (-2.8A) None 4RB A 401 (-4.4A) GOL A 503 ( 3.1A)	0.84A	5y7zB-3bqrA: 24.1	5y7zB-3bqrA: 16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA')	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 8	VAL A 27 LYS A 42 MET A 146 ILE A 160 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) 4RB A 401 (-2.8A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.70A	5y9mA-3bqrA: 23.3	5y9mA-3bqrA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 8	VAL A 27 LYS A 42 MET A 146 ILE A 160 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) 4RB A 401 (-2.8A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.70A	5y9mX-3bqrA: 23.4	5y9mX-3bqrA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	5 / 7	VAL A 27 LYS A 42 MET A 146 ILE A 160 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) 4RB A 401 (-2.8A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.82A	5yf9B-3bqrA: 23.2	5yf9B-3bqrA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	6 / 9	VAL A 27 LYS A 42 ILE A 77 MET A 146 ILE A 160 ASP A 161	4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.3A) 4RB A 401 (-2.8A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.79A	5yf9X-3bqrA: 23.8	5yf9X-3bqrA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YWM_X_NIOX403_0 (CASEIN KINASE II SUBUNIT ALPHA')	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	LYS A 42 ILE A 77 ILE A 160 ASP A 161	4RB A 401 ( 2.8A) 4RB A 401 ( 4.3A) 4RB A 401 (-3.5A) GOL A 503 ( 3.1A)	0.29A	5ywmX-3bqrA: 23.4	5ywmX-3bqrA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YWM_X_NIOX403_0 (CASEIN KINASE II SUBUNIT ALPHA')	3bqr	DEATH-ASSOCIATED PROTEIN KINASE 3 (Homo sapiens)	4 / 7	VAL A 27 LYS A 42 ILE A 77 ILE A 160	4RB A 401 ( 4.4A) 4RB A 401 ( 2.8A) 4RB A 401 ( 4.3A) 4RB A 401 (-3.5A)	0.36A	5ywmX-3bqrA: 23.4	5ywmX-3bqrA: 16.46

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1IEP_B_STIB202_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"LEU A  19;VAL A  27;ALA A  40;GLU A  64;ILE A  71;GLY A  99","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);GOL A 503 (-2.8A);None;None","0.72A","1iepB-3bqrA:20.6",null],["1UWH_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;GLU A  64;LEU A  68;LEU A 130;HIS A 137","4RB A 401 (-3.3A);GOL A 503 (-2.8A);None;None;None","0.54A","1uwhA-3bqrA:22.5","1iepB-3bqrA:26.92"],["1UWH_B_BAXB1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"ALA A  40;LYS A  42;GLU A  64;LEU A  68;LEU A 130;HIS A 137","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;None;None","0.60A","1uwhB-3bqrA:22.4","1uwhA-3bqrA:27.12"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"LEU A  19;VAL A  27;LEU A  79;LEU A  91;LEU A  95","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);PGO A 501 ( 4.6A);None;4RB A 401 (-4.4A)","0.47A","1xkkA-3bqrA:20.9","1uwhB-3bqrA:27.12"],["1YI4_A_ADNA306_1","PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE PIM-1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"LEU A  19;ALA A  40;ILE A  77;LEU A  93;ILE A 160","4RB A 401 ( 3.9A);4RB A 401 (-3.3A);4RB A 401 ( 4.3A);4RB A 401 ( 4.1A);4RB A 401 (-3.5A)","0.80A","1yi4A-3bqrA:26.1","1xkkA-3bqrA:24.86"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"LEU A  19;VAL A  27;ALA A  40;VAL A  96;ASP A 139;LYS A 141;ASN A 144;MET A 146","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);None;None;None;4RB A 401 (-2.8A)","0.84A","2fumA-3bqrA:25.8","1yi4A-3bqrA:30.10"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"VAL A  27;ALA A  40;VAL A  96;ASP A 139;LYS A 141;ASN A 144;MET A 146;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);None;None;None;4RB A 401 (-2.8A);GOL A 503 ( 3.1A)","0.77A","2fumA-3bqrA:25.8","2fumA-3bqrA:28.57"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"LEU A  19;GLY A  20;VAL A  27;ALA A  40;VAL A  96;MET A 146","4RB A 401 ( 3.9A);4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);4RB A 401 (-2.8A)","0.82A","2fumC-3bqrA:24.5","2fumA-3bqrA:28.57"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"LEU A  19;VAL A  27;ALA A  40;VAL A  96;ASN A 144;MET A 146","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);None;4RB A 401 (-2.8A)","0.81A","2fumC-3bqrA:24.5","2fumC-3bqrA:28.57"],["2ITY_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"LEU A  19;GLY A  20;VAL A  27;ALA A  40;LYS A  42;GLU A  64;LEU A  91;ASP A 161","4RB A 401 ( 3.9A);4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;GOL A 503 ( 3.1A)","0.75A","2ityA-3bqrA:22.4","2fumC-3bqrA:28.57"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"GLY A  20;VAL A  27;ALA A  40;LEU A  93;MET A 146;ASP A 161","4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);4RB A 401 (-2.8A);GOL A 503 ( 3.1A)","0.74A","2wgjA-3bqrA:20.9","2ityA-3bqrA:25.22"],["2YGQ_A_PCFA1275_0","WNT INHIBITORY FACTOR 1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"LEU A 210;ILE A 123;LEU A 159;ILE A 206;ILE A 160","None;None;None;None;4RB A 401 (-3.5A)","1.04A","2ygqA-3bqrA:undetectable","2wgjA-3bqrA:25.98"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"ALA A  40;GLU A  64;LEU A  68;ILE A  77;HIS A 137;ASP A 161","4RB A 401 (-3.3A);GOL A 503 (-2.8A);None;4RB A 401 ( 4.3A);None;GOL A 503 ( 3.1A)","1.17A","3gp0A-3bqrA:21.0","2ygqA-3bqrA:19.69"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  27;ALA A  40;GLU A  64;LEU A  68;ILE A  77;HIS A 137","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);GOL A 503 (-2.8A);None;4RB A 401 ( 4.3A);None","0.65A","3gp0A-3bqrA:21.0","3gp0A-3bqrA:27.98"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;LYS A  42;GLU A  64;LEU A  68;LEU A  95","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;4RB A 401 (-4.4A)","0.56A","3hecA-3bqrA:21.0","3gp0A-3bqrA:27.98"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;LYS A  42;LEU A  68;ILE A  77;LEU A  95","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;4RB A 401 ( 4.3A);4RB A 401 (-4.4A)","0.66A","3hecA-3bqrA:21.0","3hecA-3bqrA:28.01"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;ALA A  40;LYS A  42;LEU A  68;ILE A  77","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;4RB A 401 ( 4.3A)","0.60A","3hegA-3bqrA:20.7","3hecA-3bqrA:28.01"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;LYS A  42;GLU A  64;LEU A  91;LEU A  95","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;4RB A 401 (-4.4A)","0.53A","3lfaA-3bqrA:21.2","3hegA-3bqrA:28.01"],["3OHT_A_1N1A1000_1","P38A","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"GLY A  20;VAL A  27;ALA A  40;LYS A  42;LEU A  68;ILE A  77","4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;4RB A 401 ( 4.3A)","0.61A","3ohtA-3bqrA:4.0","3lfaA-3bqrA:27.35"],["3OHT_B_1N1B1000_1","P38A","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"GLY A  20;VAL A  27;ALA A  40;LYS A  42;LEU A  68;ILE A  77","4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;4RB A 401 ( 4.3A)","0.61A","3ohtB-3bqrA:18.6","3ohtA-3bqrA:25.44"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",7,"VAL A  27;ALA A  40;GLU A  64;LEU A  68;ILE A  77;LEU A 130;HIS A 137","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);GOL A 503 (-2.8A);None;4RB A 401 ( 4.3A);None;None","0.58A","3rgfA-3bqrA:21.8","3ohtB-3bqrA:25.44"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",7,"LEU A  19;VAL A  27;ALA A  40;LYS A  42;LEU A  91;LEU A  95;ASP A 103","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;4RB A 401 (-4.4A);None","0.70A","3ug2A-3bqrA:21.7","3rgfA-3bqrA:26.56"],["3WAR_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"LYS A  42;ILE A  77;MET A 146;ILE A 160;ASP A 161","4RB A 401 ( 2.8A);4RB A 401 ( 4.3A);4RB A 401 (-2.8A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.38A","3warA-3bqrA:24.5","3ug2A-3bqrA:25.29"],["3WAR_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;LYS A  42;ILE A  77;MET A 146;ILE A 160","4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);4RB A 401 ( 4.3A);4RB A 401 (-2.8A);4RB A 401 (-3.5A)","0.38A","3warA-3bqrA:24.5","3warA-3bqrA:27.84"],["3WZE_A_BAXA1201_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",7,"LEU A  19;VAL A  27;ALA A  40;LYS A  42;LEU A  68;ILE A  71;HIS A 137","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;None;None","0.61A","3wzeA-3bqrA:20.2","3warA-3bqrA:27.84"],["3WZE_A_BAXA1201_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",7,"VAL A  27;ALA A  40;LYS A  42;LEU A  68;ILE A  71;LEU A 130;HIS A 137","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;None;None;None","0.65A","3wzeA-3bqrA:20.2","3wzeA-3bqrA:27.19"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"LEU A  19;ALA A  40;LEU A  93;LEU A  95;ASP A 161","4RB A 401 ( 3.9A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);4RB A 401 (-4.4A);GOL A 503 ( 3.1A)","0.42A","3zbfA-3bqrA:23.3","3wzeA-3bqrA:27.19"],["4ASD_A_BAXA1500_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",9,"LEU A  19;VAL A  27;ALA A  40;LYS A  42;GLU A  64;LEU A  68;GLY A  99;LEU A 130;HIS A 137","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;None;None;None","0.82A","4asdA-3bqrA:20.0","3zbfA-3bqrA:25.15"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"VAL A  27;ALA A  40;ILE A  77;ASP A 103;ASP A 139;ASN A 144;ILE A 160;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.3A);None;None;None;4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.61A","4i41A-3bqrA:26.0","4asdA-3bqrA:25.88"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"VAL A  27;ALA A  40;ILE A  77;ASP A 103;ASP A 139;LYS A 141;ASN A 144;ILE A 160","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.3A);None;None;None;None;4RB A 401 (-3.5A)","0.68A","4i41A-3bqrA:26.0","4i41A-3bqrA:29.73"],["4IAA_A_RTZA401_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  27;ALA A  40;LYS A  42;LEU A  93;ILE A 160;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);4RB A 401 ( 4.1A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.40A","4iaaA-3bqrA:26.0","4i41A-3bqrA:29.73"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"GLY A  20;VAL A  27;ALA A  40;LEU A  79;LEU A  91;GLY A  99;GLU A 100;ILE A 160","4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);PGO A 501 ( 4.6A);None;None;4RB A 401 (-3.8A);4RB A 401 (-3.5A)","0.46A","4ifgA-3bqrA:25.0","4iaaA-3bqrA:29.51"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",7,"LEU A  19;VAL A  27;ALA A  40;LYS A  42;LEU A  93;LEU A  95;ASP A 161","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);4RB A 401 ( 4.1A);4RB A 401 (-4.4A);GOL A 503 ( 3.1A)","0.50A","4mkcA-3bqrA:21.7","4ifgA-3bqrA:23.83"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;LYS A  42;ILE A  77;LEU A  95;VAL A  96","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);4RB A 401 ( 4.3A);4RB A 401 (-4.4A);4RB A 401 ( 4.1A)","0.45A","4rz7A-3bqrA:6.9","4mkcA-3bqrA:23.12"],["4V01_A_0LIA1776_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;GLU A  64;ILE A  71;LEU A 130;HIS A 137","4RB A 401 (-3.3A);GOL A 503 (-2.8A);None;None;None","0.83A","4v01A-3bqrA:20.2","4rz7A-3bqrA:14.69"],["4WKQ_A_IREA1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"LEU A  19;ALA A  40;LYS A  42;GLU A  64;LEU A  91;LEU A  95","4RB A 401 ( 3.9A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;4RB A 401 (-4.4A)","0.49A","4wkqA-3bqrA:22.3","4v01A-3bqrA:25.08"],["4XV2_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"ALA A  40;LYS A  42;LEU A  68;ASP A 161;PHE A 162","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;GOL A 503 ( 3.1A);None","0.76A","4xv2B-3bqrA:22.7","4wkqA-3bqrA:25.87"],["5CSW_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;ALA A  40;LYS A  42;LEU A  68;PHE A 162","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;None","0.73A","5cswA-3bqrA:22.4","4xv2B-3bqrA:28.53"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;ALA A  40;LYS A  42;LEU A  68;PHE A 162","4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);None;None","0.75A","5cswB-3bqrA:22.4","5cswA-3bqrA:28.12"],["5HI2_A_BAXA801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"ALA A  40;LYS A  42;GLU A  64;LEU A  68;LEU A 130;HIS A 137","4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;None;None","0.70A","5hi2A-3bqrA:23.2","5cswB-3bqrA:28.12"],["5IZF_E_AZ1E2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;6J9-ZEU-DAR-ACA-DAR-NH2","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",4,"GLY A  20;GLY A  22;LYS A  42;GLU A 100","4RB A 401 (-3.6A);None;4RB A 401 ( 2.8A);4RB A 401 (-3.8A)","0.52A","5izfA-3bqrA:20.4","5hi2A-3bqrA:28.85"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",4,"GLY A  20;GLY A  22;VAL A  27;LYS A  42","4RB A 401 (-3.6A);None;4RB A 401 ( 4.4A);4RB A 401 ( 2.8A)","0.37A","5izjA-3bqrA:19.3","5izfA-3bqrA:26.94"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"GLY A  20;GLY A  22;VAL A  27;LYS A  42;ASP A 161","4RB A 401 (-3.6A);None;4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);GOL A 503 ( 3.1A)","0.78A","5j5xA-3bqrA:26.0","5izjA-3bqrA:26.94"],["5LVN_A_ADNA402_1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"LEU A  19;GLY A  20;VAL A  27;ALA A  40;LEU A  93;GLU A 100","4RB A 401 ( 3.9A);4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.1A);4RB A 401 (-3.8A)","0.47A","5lvnA-3bqrA:27.8","5j5xA-3bqrA:26.94"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"GLY A  20;VAL A  27;ALA A  40;ILE A  77;LEU A  95","4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 4.3A);4RB A 401 (-4.4A)","0.65A","5lw1E-3bqrA:20.6","5lvnA-3bqrA:27.71"],["5MAF_A_XINA403_1","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",8,"GLU A  17;GLY A  20;VAL A  27;ALA A  40;LYS A  42;GLU A  64;LEU A  93;GLU A 100","None;4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);4RB A 401 ( 4.1A);4RB A 401 (-3.8A)","0.83A","5mafA-3bqrA:28.5","5lw1E-3bqrA:12.82"],["5MAF_A_XINA403_1","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",9,"GLU A  17;GLY A  20;VAL A  27;ALA A  40;LYS A  42;LEU A  93;GLY A  99;GLU A 100;ILE A 160","None;4RB A 401 (-3.6A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);4RB A 401 ( 4.1A);None;4RB A 401 (-3.8A);4RB A 401 (-3.5A)","0.80A","5mafA-3bqrA:28.5","5mafA-3bqrA:13.04"],["5VCY_A_DB8A401_1","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"LEU A  19;VAL A  27;ALA A  40;LYS A  42;GLU A  64;LEU A  91","4RB A 401 ( 3.9A);4RB A 401 ( 4.4A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None","0.66A","5vcyA-3bqrA:23.9","5mafA-3bqrA:13.04"],["5Y7Z_B_IREB401_0","CYCLIN-G-ASSOCIATED KINASE","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",7,"LEU A  19;ALA A  40;LYS A  42;GLU A  64;LEU A  91;LEU A  95;ASP A 161","4RB A 401 ( 3.9A);4RB A 401 (-3.3A);4RB A 401 ( 2.8A);GOL A 503 (-2.8A);None;4RB A 401 (-4.4A);GOL A 503 ( 3.1A)","0.84A","5y7zB-3bqrA:24.1","5vcyA-3bqrA:26.59"],["5Y9M_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA'","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;LYS A  42;MET A 146;ILE A 160;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);4RB A 401 (-2.8A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.70A","5y9mA-3bqrA:23.3","5y7zB-3bqrA:16.18"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;LYS A  42;MET A 146;ILE A 160;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);4RB A 401 (-2.8A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.70A","5y9mX-3bqrA:23.4","5y9mA-3bqrA:16.46"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",5,"VAL A  27;LYS A  42;MET A 146;ILE A 160;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);4RB A 401 (-2.8A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.82A","5yf9B-3bqrA:23.2","5y9mX-3bqrA:16.46"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",6,"VAL A  27;LYS A  42;ILE A  77;MET A 146;ILE A 160;ASP A 161","4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);4RB A 401 ( 4.3A);4RB A 401 (-2.8A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.79A","5yf9X-3bqrA:23.8","5yf9B-3bqrA:16.46"],["5YWM_X_NIOX403_0","CASEIN KINASE II SUBUNIT ALPHA'","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",4,"LYS A  42;ILE A  77;ILE A 160;ASP A 161","4RB A 401 ( 2.8A);4RB A 401 ( 4.3A);4RB A 401 (-3.5A);GOL A 503 ( 3.1A)","0.29A","5ywmX-3bqrA:23.4","5yf9X-3bqrA:16.46"],["5YWM_X_NIOX403_0","CASEIN KINASE II SUBUNIT ALPHA'","3bqr","DEATH-ASSOCIATED PROTEIN KINASE 3","Homo sapiens",4,"VAL A  27;LYS A  42;ILE A  77;ILE A 160","4RB A 401 ( 4.4A);4RB A 401 ( 2.8A);4RB A 401 ( 4.3A);4RB A 401 (-3.5A)","0.36A","5ywmX-3bqrA:23.4","5ywmX-3bqrA:16.46"]]